SCHEDULE: Bigger Capital Group Discloses 7.8% Stake in ClearPoint Neuro

Michael Bigger and affiliated entities disclose a combined 7.8% beneficial ownership in ClearPoint Neuro, Inc. through a Schedule 13G Amendment.

Summary

• Bigger Capital Fund L P and its general partner, Bigger Capital Fund GP, LLC, beneficially own 1,333,155 shares of ClearPoint Neuro, Inc. common stock, representing 4.69% of the outstanding shares.
• District 2 Capital Fund LP, along with its investment manager District 2 Capital LP, general partner District 2 GP LLC, and managing member District 2 Holdings LLC, beneficially own 337,696 shares, representing 1.19% of the outstanding shares.
• Michael Bigger, as the managing member of Bigger Capital Fund GP, LLC and District 2 Holdings LLC, is deemed to beneficially own an aggregate of 2,216,543 shares, which includes his direct holdings, shares held by Bigger Capital and District 2 Capital Fund, and shares held by his spouse and sons.
• Michael Bigger's total beneficial ownership represents approximately 7.8% of ClearPoint Neuro, Inc.'s outstanding common stock.
• Patricia Winter, Michael Bigger's spouse, holds 167,000 shares, which is reported as 0% of the outstanding common stock in her individual filing.
• The percentages are based on 28,423,308 shares of Common Stock outstanding as of October 27, 2025, as reported in the Issuer's Form 10-Q filed on November 6, 2025.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive disclosure. While a Schedule 13G is a mandatory filing, the aggregation of a 7.8% beneficial ownership by Michael Bigger and related entities signals a notable, albeit passive, investment interest in ClearPoint Neuro, Inc.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures of passive beneficial ownership and do not typically provide direct industry context or strategic insights beyond the ownership stake itself. This filing indicates a significant, albeit passive, investment by Michael Bigger and associated entities in ClearPoint Neuro, Inc.

Stakeholder Impact

• Shareholders: The disclosure of a significant beneficial ownership stake by a group of investors, including Michael Bigger, may be viewed as a sign of confidence in the company, potentially influencing investor sentiment.

Key Dates

Keywords

ClearPoint Neuro, Bigger Capital, District 2 Capital, Michael Bigger, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Investment